Health TrialsbyHealthPanel

COPD at a Street Level

ConditionCOPD
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorHvidovre University Hospital

About this trial

The trial investigates and describes the prevalence of COPD among socially vulnerable individuals who come in contact with a mobile clinic and investigates the effect of opportunistic screening for COPD in these vulnerable persons. The study population is individuals who come in contact with a mobile clinic, that visits home shelters, open drugs scenes etc. in the Capital Region of Denmark during the inclusion period, and monitor them for up to 1 year in order to investigate variables that are significant in terms of the patients' treatment, hospitalizations, and mortality in relation to COPD. Our hypothesis is that there will be a higher incidence of COPD among socially vulnerable individuals who come in contact with the mobile clinic than in the general population.

Eligibility criteria

This trial accepts healthy volunteers

Qualifiers

18 years or older

Able to speak and understand Danish or English to such an extent that informed consent can be obtained

Disqualifiers

None

Trial design

Design model

Single group

Treatments tested in this trial

  • Spirometry

    Diagnostic test

    The method of examination, Spirometry, is noninvasive (i.e. not an intervention that involves penetration into the body by means of incisions or injections.). It is a routine examination and there are no risks, adverse reactions, or discomforts associated with the examination.

Treatment groups

511 Participants
are divided into 1 treatment group
Group A: Socially vulnerable individuals in contact with a mobile clinicOther 1 intervention

Trial outcomes

Primary outcomes

1

Prevalence of COPD

1\. Prevalence of obstructive lung function reduction among socially vulnerable

Time frame
Baseline
2

Undiagnosed COPD

2\. Prevalence of previously undetected COPD

Time frame
Baseline
3

Adherence to first appointment

3\. Numbers of socially vulnerable individuals diagnosed with obstructive lung function that are subsequently examined at a pulmonary medicine outpatient clinic/GP

Time frame
Baseline
4

Subscription at first appointment

4\. Number of socially vulnerable individuals who after COPD diagnosis are subscribed medical treatment

Time frame
Baseline

Secondary outcomes

1

Smoking status

5\. Prevalence of socially vulnerable individuals who smoke and wish to stop smoking

Time frame
Baseline
2

COPD and smoking cessation

6\. Prevalence of socially vulnerable individuals with impaired lung function who have a desire to stop smoking

Time frame
Baseline
3

smoking cessation invitation

7\. Prevalence of socially vulnerable individuals who want to quit smoking and accept the smoking cessation offers

Time frame
Baseline
4

Adherence to treatment

8\. Prevalence of socially vulnerable individuals who claim their prescription for COPD medication

Time frame
Baseline

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Hvidovre University Hospital

Lead sponsor

Brugernes Akademi

Collaborator

Source ClinicalTrials.gov
Apply now